Page results
-
This page is for patients who are going to receive whole brain radiotherapy to the brain if your cancer has spread there.
-
Online form for beginning the sefl referral process at UCLH maternity services.
-
We offer weekly neuro-rehabilitation assessment clinics where our patients are assessed by a multidisciplinary team.
-
The department undertakes specialist dental treatment for those under 16 years of age ( 15 years and 11 months), and deals with the aetiology, prevention, diagnosis and treatment of oral disorders; mouth conditions and teeth of children.
-
Overview of the UCLH ambulatory care service for adults with cancer. This service allows people to have their cancer treatment at outpatient appointments, without needing to stay overnight in hospital.
-
The cardiovascular health and rehabilitation service at UCLH is made up of a multidisciplinary team of cardiac nurses, health professionals and exercise specialists.
-
UCLH works in partnership with GPs in Barnet and Enfield to provide a community based ear, nose and throat (ENT) service. The Community ENT service provides specialist advice and treatment for a range of minor ENT conditions.
-
The primary objective of the ENT urgent referral clinic is to provide speedy access and effective care to all adult and paediatric patients aged above two years old with urgent ENT problems.
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Radiotherapy Department Patient Information series no. 18 - prostate brachytherapy prostate high dose rate (HDR) brachytherapy
File results
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis